4D Molecular Therapeutics...

NASDAQ: FDMT · Real-Time Price · USD
7.28
0.18 (2.54%)
At close: Aug 15, 2025, 3:59 PM
7.23
-0.62%
After-hours: Aug 15, 2025, 07:58 PM EDT

4D Molecular Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-196.14M -176.44M -160.87M -143.48M -109.89M -104.56M -100.84M -95.93M -111.37M -109.84M -107.49M -105.2M -101.75M -81.25M -71.32M -66.78M -52.38M -59.94M
Depreciation & Amortization
7.13M 6.87M 6.71M 6.43M 6.13M 5.93M 5.75M 5.62M 5.11M 4.51M 3.88M 4.38M 3.88M 3.42M 3.02M 1.5M 1.49M 1.48M
Stock-Based Compensation
26.01M 27.13M 26.11M 24.45M 22.52M 21.42M 19.66M 18.1M 18.06M 17.41M 17.12M 16.51M 15.91M 15.4M 13.8M 11.79M 9.01M 6.23M
Other Working Capital
-2.1M -3.05M -334K 6.6M -645K -331K -266K -3.94M -4.94M -3.04M -106K -3.7M -3.46M -18.77M -19.26M -12.81M -17.89M -42K
Other Non-Cash Items
-2.29M -3.44M 5.64M 7.65M 5.63M 7.72M -369K -753K -530K 167K 1.14M 2.09M 1.87M 1.39M 898K 212K 188K 171K
Deferred Income Tax
n/a n/a n/a -630K -630K -630K -630K n/a n/a n/a n/a n/a 7K n/a 94K 94K 87K 94K
Change in Working Capital
-1.09M -7.37M -3.72M 664K -446K 1.6M 630K -392K -4.47M -3.29M -1.34M -4.09M -926K -16.28M -15.53M -11.52M -20.76M -353K
Operating Cash Flow
-166.39M -153.25M -134.59M -113.37M -85.15M -76.97M -75.79M -73.36M -93.2M -91.04M -86.69M -86.31M -81.01M -77.31M -69.13M -64.8M -62.45M -52.41M
Capital Expenditures
-521K -870K -949K -549K -2.01M -2.47M -2.77M -3.31M -4.87M -6.13M -11.54M -15.54M -16.21M -14.88M -9.11M -4.52M -1.54M -921K
Cash Acquisitions
n/a n/a n/a 49.08M 49.08M -1.01M n/a -37.55M -54.88M -64.32M -65.33M -76.87M -59.53M n/a n/a n/a n/a n/a
Purchase of Investments
-343.05M -324.4M -467.65M -444.52M -408.73M -317.4M -54.8M 80.35M -107.59M -108.35M -153.31M -286.02M -234.45M -228.26M -168.57M -136.38M n/a n/a
Sales Maturities Of Investments
398.93M 320.88M 169M 131.73M 97.25M 129.19M 173.29M 9.58M 184.47M 194.67M 147.8M 287.99M 82.72M 17M 5M n/a n/a n/a
Other Investing Acitivies
-2.84M -2.84M -3.55M -52.63M -19.41M 30.69M 30.39M 67.93M 54.88M 64.32M 17.64M 34.17M -119.54M -179.07M -132.02M -138.02M -1.64M -1.64M
Investing Cash Flow
52.46M -7.23M -302.44M -316.18M -313.5M -190.67M 115.72M 86.62M 72.01M 80.19M -17.05M -13.56M -167.94M -226.15M -172.68M -140.9M -1.54M -921K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
332.58M 334.14M 337.25M 10M 11.01M 10.25M 8.49M 5.77M 4.65M 3.8M 3.08M 117.18M 118.69M 119.56M 118.09M 2.83M 1.75M 73.42M
Financial Cash Flow
2.03M 18.42M 337.25M 341.41M 351.4M 464.67M 156.83M 154.12M 144.02M 13.45M 3.08M 117.18M 118.69M 119.56M 118.09M 207.93M 206.85M 278.52M
Net Cash Flow
-111.9M -142.07M -126.34M -114.71M -73.82M 170.46M 196.76M 167.38M 122.83M 2.6M -100.65M 17.31M -130.26M -183.9M -123.72M 2.23M 142.87M 225.19M
Free Cash Flow
-166.28M -153.49M -135.53M -113.92M -87.17M -79.44M -78.56M -76.67M -98.08M -97.18M -98.22M -101.85M -97.22M -92.19M -78.24M -69.32M -63.98M -53.33M